Skip to main content

Cancer Cells Obliterated From Human Body In A Drug Trial In USA

An experimental cancer drug proved a 100 percent success rate in a small study trial on patients with rectal cancer conducted by doctors at New York's Memorial Sloan Kettering Cancer Center.

A group of 18 anal cancer patients showed no signs of a tumor after taking antibody drugs for six months, according to surprising findings from an ongoing medical study in the United States. 

However apart from their tumors completely disappearing, none of the participants experienced any severe side effects, according to a recent study published in the New England Journal of Medicine.

The patient underwent a series of tests including a physical examination, endoscopy, cinema, PET scan, and MRI scan, but none of the results showed a tumor. 

"All 18 patients had a complete clinical response with no signs of magnetic resonance imaging," the researchers write. 

"To measure the length of reaction, a longer follow-up is required," they stressed. 

The researchers seek to see if Dostarlimab, an antibody drug, combined with standard chemoradiotherapy and surgery was an effective treatment for advanced 'deficient MisMatch Repair' (dMMR) solid tumors. 

Cells lacking MMR usually have multiple DNA mutations that cause cancer. 

According to the journal, MMR deficiency is most common in colon cancer, other types of gastrointestinal cancer, and endometrial cancer. 

Participants in the study at the Sloan Catering Memorial Cancer Center in New York City received medication every three weeks for six months if they had stage II or III rectal adenocarcinoma and they didn't heal. 



Adenocarcinoma is a type of cancer that occurs in the glands that cover our internal organs. 

Treatment should be followed by standard chemotherapy and surgery, but patients with a complete clinical response should skip both. 

All 12 patients showed a “clinically complete response” with no tumor symptoms after at least six months of follow-up.

Medical research is supported by the Simon and Yves Colin Foundation, GlaxoSmithKline, Take A stand to Cancer, Swim Across America, and the National Cancer Institute of the National Institutes of Health.




Comments

Popular posts from this blog

Israel Martyrs 70 Palestinians In Gaza In 24 hours

The Palestinian Health Ministry in Gaza says that Israeli forces have martyred 70 Palestinians in just the past day. Since Israel's war on Gaza began on October 7, 2023, the Gaza Health Ministry reported 61,897 deaths and 155,660 injuries. Seventy Palestinians were sent to hospitals during the past day, including eight who were rescued from under the debris or elsewhere, according to  Al Jazeera . At least 26 people sadly died while trying to get aid , and another 175 were injured. While trying to get food, at least 1,924 Palestinians have been confirmed martyred, and 14,288 have been injured. Since March 18, Israel has broken the previous ceasefire , completely blocked aid, and launched devastating airstrikes, resulting in at least 10,362 Palestinian deaths and 43,619 injuries, according to the ministry.

Train Collision In Spain: 39 Passengers Killed & 122 Injured

Córdoba, Spain -  At least 39 passengers were killed when two trains crashed in Córdoba at around 19:45 on Sunday.  Córdoba is a city in Andalusia, a southern region of Spain, and it is the provincial capital. According to official reports, out of 122 people who received medical care for their injuries, 48, including five children, are still in the hospital. Spanish Prime Minister Pedro Sanchez has announced three days of mourning and vowed to conduct a "thorough and absolutely transparent" investigation into the incident.  The high-speed train service between Madrid and Andalusia will be halted until at least Friday.  Local media reports that authorities have started up offices in numerous locations where victims' relatives may provide DNA samples to assist in the deceased's identification.

Pakistani President, Mr Asif Ali Zardari, Begins 4-day Iraq Visit

BAGHDAD, Iraq  —   President Asif Ali Zardari rolled into Baghdad on Saturday for an official visit all about boosting trade ties. President Zardari aims to strengthen relations with Baghdad following years of limited interaction.    "President Asif Ali Zardari arrived in Baghdad for a four-day official visit to Iraq," his office announced on social media.   Culture Minister Dr. Ahmed Fakkak Al-Badrani warmly welcomed him. The visit seeks to enhance cooperation and strengthen relations between Pakistan and Iraq through meetings with senior Iraqi leaders.   Zardari's trip is part of recent top-level meet-ups to boost ties between the two sides, focusing on economic, political, and community links.   Pakistan's foreign office announced that the president will hold discussions with Iraq's senior leaders regarding cooperation in trade, investment, energy, technology, education, and personnel. Mr Zardari is also expected to talk about regional a...